SCHEMBL4068267

SCHEMBL4068267

O=C(N[C@@H](CO)Cc1ccccc1)c1ncc2cccnc2c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 6/20 0.48
ROCK1 Q13464 6/20 0.48
MAPK1 P28482 3/20 0.48
RPS6KA5 O75582 2/20 0.48
RPS6KA4 O75676 2/20 0.48
PRKACA P17612 2/20 0.48
GSK3B P49841 2/20 0.48
PRKX P51817 2/20 0.48
PRKG1 Q13976 2/20 0.48
CLK4 Q9HAZ1 2/20 0.48
GSK3A P49840 1/20 0.48
IRAK1 P51617 1/20 0.48
PKN2 Q16513 1/20 0.48
SGK2 Q9HBY8 1/20 0.48
FEN1 P39748 1/20 0.47
EGLN1 Q9GZT9 4/20 0.46
PIN1 Q13526 1/20 0.44
EGFR P00533 1/20 0.43
CYP3A4 P08684 1/20 0.43
ECE1 P42892 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4062930 1.00 ROCK2 (0.48) ROCK2ROCK1MAPK1RPS6KA5RPS6KA4
SCHEMBL4060413 0.84 FEN1 (0.47) FEN1EGLN1SLC2A1
SCHEMBL7954435 0.84 EGLN1 (0.63) ROCK2ROCK1MAPK1RPS6KA5RPS6KA4
SCHEMBL7954438 0.84 EGLN1 (0.63) ROCK2ROCK1MAPK1RPS6KA5RPS6KA4
SCHEMBL4060889 0.82 FEN1 (0.48) ROCK2ROCK1MAPK1RPS6KA5PRKACA
SCHEMBL4066741 0.79 EGLN1 (0.69) FEN1EGLN1EGFR
SCHEMBL4063678 0.78 ROCK1 (0.48) ROCK2ROCK1PRKACAGSK3BPRKX
SCHEMBL4058387 0.77 EGLN1 (0.70) FEN1EGLN1EGFR
SCHEMBL6492038 0.77 ELANE (0.53) FEN1EGLN1CYP3A4SLC2A1
SCHEMBL4059832 0.77 MAOA (0.60) ROCK2ROCK1MAPK1RPS6KA5PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921759-B2 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2005-07-26 US claimed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US claimed
EP-1326865-B1 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-05-06 EP disclosed
EP-1326865-B1 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-05-06 EP disclosed
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors ANTHONY NEVILLE J (US) 2005-08-11 US disclosed
US-6921759-B2 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2005-07-26 US disclosed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA ROCK2 3321/4885ROCK1 3351/4885MAPK1 4138/4885
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA ROCK2 3321/4885ROCK1 3351/4885MAPK1 4138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.